An op-ed by Chrissy Buteas, President and CEO of the HealthCare Institute of New Jersey (HINJ), emphasizes the need for a balanced approach in addressing prescription drug affordability. The focus is on helping patients without hindering future medical advancements.
Buteas highlights that health care costs are a significant concern for various stakeholders, including patients, families, businesses, and governments. She notes that these costs can impact individuals' ability to live healthy and independent lives or worsen existing conditions.
The op-ed calls for the newly established Prescription Drug Affordability Council to carefully consider both affordability and innovation when making decisions. "There is near-universal agreement that ensuring people can afford health care is of the utmost importance," Buteas states.
Readers are encouraged to explore the full op-ed for a more comprehensive understanding of her perspective on this pressing issue.
